ReviewPest management science2026
Biogenic nanomaterials: A green strategy for sustainable vector-borne disease management.
Review in Pest management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Vector-borne diseases (VBDs) remain a major global health threat, affecting millions of people annually through pathogens transmitted by vectors such as mosquitoes and ticks. Climate change and rising pesticide resistance have exacerbated the prevalence of these diseases, highlighting the urgent need for innovative and sustainable control strategies. In recent years, nanotechnology has shown great potential in the design and development of novel agrochemicals capable of precisely targeting insect vectors. This review explores the potential of biogenic nanomaterials as eco-friendly and effective tools in the fight against VBDs. We summarize the biogenic synthesis methods for nanoparticles and emphasize their environmental sustainability and biological efficacy. Furthermore, we highlight the latest advances in the application of nanomaterials for VBD management, focusing on their mechanisms of action, effectiveness, and biosafety. Ultimately, this review underscores the promise of biogenic nanomaterials as sustainable solutions (RNA interference and nano-vaccines) for vector control and their potential to drive future innovations in public health. © 2026 Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.